Management issues for women with epilepsy - A review of the literature

被引:87
作者
Zahn, CA
Morrell, MJ
Collins, SD
Labiner, DM
Yerby, MS
机构
[1] Toronto Hosp, Western Div, Div Neurol, Toronto, ON M5T 2S8, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Stanford Univ, Sch Med, Stanford Comprehens Epilepsy Ctr, Stanford, CA 94305 USA
[4] Case Western Reserve Univ, Comprehens Epilepsy Ctr, Cleveland, OH 44106 USA
[5] Arizona Hlth Sci Ctr, Dept Neurol, Tucson, AZ 85724 USA
[6] Oregon Hlth Sci Univ, Portland, OR 97201 USA
关键词
D O I
10.1212/WNL.51.4.949
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: A review of literature referable to management issues for women with epilepsy (WWE) was undertaken for the development of a practice parameter. Background: Epilepsy is a common neurologic condition with gender-related management implications. Although reviews of this topic often focus on pregnancy-related issues for WWE, specific health concerns for WWE are present throughout all phases of reproductive life. Methods: An OVID MEDLINE literature search was conducted for 1965 to 1997 using the following key words/phrases and cross referencing: epilepsy/seizures and pregnancy, anticonvulsants, antiepileptic drugs (AEDs), teratogenesis, oral contraceptives, birth defects, folate/folic acid, vitamin K, metabolic bone disease, and breast-feeding. Results: Pregnancy outcome literature for WWE spans several decades. Methodology varies and interpretation is complicated by modern management strategies. Contributions of socioeconomic factors, AEDs, maternal epilepsy, and seizures during pregnancy to adverse pregnancy outcomes have not been clearly delineated. There is a biologic basis for recommendations concerning contraception, folate supplementation, vitamin K use in pregnancy, breast-feeding, metabolic bone disease, catamenial epilepsy, and reproductive endocrine disorders, but no outcome studies afford a strong evidence base for practice recommendation. Conclusions: WWE face health issues for which there is no available outcome literature to guide decision making. The urgent need for studies in many of these areas is highlighted by expanded treatment options with new AEDs and epilepsy surgery.
引用
收藏
页码:949 / 956
页数:8
相关论文
共 84 条
[1]  
[Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
[2]   THE INTERACTION OF PHENOBARBITAL AND OTHER ANTICONVULSANTS WITH ORAL-CONTRACEPTIVE STEROID-THERAPY [J].
BACK, DJ ;
BATES, M ;
BOWDEN, A ;
BRECKENRIDGE, AM ;
HALL, MJ ;
JONES, H ;
MACIVER, M ;
ORME, M ;
PERUCCA, E ;
RICHENS, A ;
ROWE, PH ;
SMITH, E .
CONTRACEPTION, 1980, 22 (05) :495-503
[3]  
BACKSTROM T, 1979, ACTA NEUROL SCAND, V59, P63
[4]  
BACKSTROM T, 1984, ACTA NEUROL SCAND, V69, P240
[5]  
BATTINO D, 1992, ACTA NEUROL SCAND, V85, P204
[6]  
BILO L, 1991, FERTIL STERIL, V55, P705
[7]  
BLUMBERG RW, 1961, PEDIATRICS, V28, P501
[8]   PRENATAL PREDICTION OF RISK OF THE FETAL HYDANTOIN SYNDROME [J].
BUEHLER, BA ;
DELIMONT, D ;
VANWAES, M ;
FINNELL, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (22) :1567-1572
[9]   INCREASED INCIDENCE OF NEONATAL VITAMIN-K DEFICIENCY RESULTING FROM MATERNAL ANTICONVULSANT THERAPY [J].
CORNELISSEN, M ;
STEEGERSTHEUNISSEN, R ;
KOLLEE, L ;
ESKES, T ;
VOGELSMENTINK, G ;
MOTOHARA, K ;
DEABREU, R ;
MONNENS, L .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (03) :923-928
[10]   SUPPLEMENTATION OF VITAMIN-K IN PREGNANT-WOMEN RECEIVING ANTICONVULSANT THERAPY PREVENTS NEONATAL VITAMIN-K DEFICIENCY [J].
CORNELISSEN, M ;
STEEGERSTHEUNISSEN, R ;
KOLLEE, L ;
ESKES, T ;
MOTOHARA, K ;
MONNENS, L .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (03) :884-888